BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9839807)

  • 21. Ultraviolet B-induced melanoma in Monodelphis domestica occurs in the absence of alterations in the structure or expression of the p53 gene.
    Wang Z; Atencio J; Robinson ES; McCarrey JR
    Melanoma Res; 2001 Jun; 11(3):239-45. PubMed ID: 11468512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chimeras of p14ARF and p16: functional hybrids with the ability to arrest growth.
    Williams RT; Barnhill LM; Kuo HH; Lin WD; Batova A; Yu AL; Diccianni MB
    PLoS One; 2014; 9(2):e88219. PubMed ID: 24505435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affected members of melanoma-prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19ARF.
    Liu L; Goldstein AM; Tucker MA; Brill H; Gruis NA; Hogg D; Lassam NJ
    Genes Chromosomes Cancer; 1997 May; 19(1):52-4. PubMed ID: 9135995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of fibroblast growth factors in ultraviolet radiation-induced corneal tumors and corneal tumor cell lines from Monodelphis domestica.
    Sabourin CL; Kusewitt DF; Applegate LA; Budge CL; Ley RD
    Mol Carcinog; 1993; 7(3):197-205. PubMed ID: 7683886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P; Schmidt M; Hu X; Wolff L
    Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.
    Hashemi J; Platz A; Ueno T; Stierner U; Ringborg U; Hansson J
    Cancer Res; 2000 Dec; 60(24):6864-7. PubMed ID: 11156381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of CDKN2A/B and Retinoblastoma genes in Xiphophorus melanoma.
    Butler AP; Trono D; Coletta LD; Beard R; Fraijo R; Kazianis S; Nairn RS
    Comp Biochem Physiol C Toxicol Pharmacol; 2007 Feb; 145(1):145-55. PubMed ID: 17011832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.
    Krimpenfort P; Quon KC; Mooi WJ; Loonstra A; Berns A
    Nature; 2001 Sep; 413(6851):83-6. PubMed ID: 11544530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of germline CDK6 mutations in familial melanoma.
    Shennan MG; Badin AC; Walsh S; Summers A; From L; McKenzie M; Goldstein AM; Tucker MA; Hogg D; Lassam N
    Oncogene; 2000 Mar; 19(14):1849-52. PubMed ID: 10777219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition.
    Abdel-Rahman MH; Pilarski R; Massengill JB; Christopher BN; Noss R; Davidorf FH
    Melanoma Res; 2011 Jun; 21(3):175-9. PubMed ID: 21412176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative structure and characterization of a CDKN2 gene in a Xiphophorus fish melanoma model.
    Kazianis S; Morizot DC; Coletta LD; Johnston DA; Woolcock B; Vielkind JR; Nairn RS
    Oncogene; 1999 Sep; 18(36):5088-99. PubMed ID: 10490845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline mutation of ARF in a melanoma kindred.
    Hewitt C; Lee Wu C; Evans G; Howell A; Elles RG; Jordan R; Sloan P; Read AP; Thakker N
    Hum Mol Genet; 2002 May; 11(11):1273-9. PubMed ID: 12019208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.
    FitzGerald MG; Harkin DP; Silva-Arrieta S; MacDonald DJ; Lucchina LC; Unsal H; O'Neill E; Koh J; Finkelstein DM; Isselbacher KJ; Sober AJ; Haber DA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8541-5. PubMed ID: 8710906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mutations in the p16/CDKN2A binding region of the cyclin-dependent kinase-4 gene.
    Tsao H; Benoit E; Sober AJ; Thiele C; Haluska FG
    Cancer Res; 1998 Jan; 58(1):109-13. PubMed ID: 9426066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines.
    Pollock PM; Yu F; Qiu L; Parsons PG; Hayward NK
    Oncogene; 1995 Aug; 11(4):663-8. PubMed ID: 7651729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photoreactivation of ultraviolet radiation-induced skin and eye tumors of Monodelphis domestica.
    Ley RD; Applegate LA; Fry RJ; Sanchez AB
    Cancer Res; 1991 Dec; 51(24):6539-42. PubMed ID: 1742727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-species application of cDNA microarrays to profile gene expression using UV-induced melanoma in Monodelphis domestica as the model system.
    Wang Z; Dooley TP; Curto EV; Davis RL; VandeBerg JL
    Genomics; 2004 Apr; 83(4):588-99. PubMed ID: 15028282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Alternative protein p19ARF: a genuine tumor suppressor gene].
    Larsen CJ
    Bull Cancer; 1998 Apr; 85(4):304-6. PubMed ID: 9752293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and mapping of swine cyclin-dependent kinase inhibitor CDKN2A and CDKN2B exon 2 sequences.
    Le Chalony C; Hayes H; Frelat G; Geffrotin C
    Cytogenet Cell Genet; 2000; 88(3-4):240-3. PubMed ID: 10828598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.